Introduction
============

Pathogenic bacteria widely exist in human habitats. As the causative agents of various infectious diseases, several bacteria, such as *Escherichia coli* O157:H7 (*E. coli* O157:H7) and *Vibrio cholerae* O1, if not treated properly, would often cause death [@B1]-[@B3]. Normally, the pathogenic bacteria infect humans through the food, water, and air. To decrease bacterial infections, rapid and accurate quantification of the pathogenic bacteria is urgently needed in all health- and safety-related areas, such as clinical diagnosis, disease prevention, environmental analysis and food safety [@B4]. Normally, the assays for pathogenic bacteria are performed based on the molecular diagnostic methods for the detection of nucleic acids in clinical and environmental samples. Although these assays showed high sensitivity and specificity, the time-consuming and laborious preparation of target DNA limit their widespread applications. Recently, various platforms have been developed to overcome these limitations, including electrochemical biosensors, surface-enhanced Raman scattering, fluorescent assays, optical sensors, and localized surface plasmon resonance [@B5]-[@B10].

Electrochemical biosensors, as a powerful analytical technique with simple preparation, fast analysis, high sensitivity and uncomplicated instrumentation, have attracted significant attention. Thus, it was considered as an artificial choice for efficient and sensitive detection of pathogenic bacteria [@B11]-[@B13]. Recently, we have developed sensitive electrochemical biosensors for amperometric detection of *E. coli* O157:H7 and acceptable applications have been obtained based on these proposed electrochemical biosensors [@B14]-[@B16]. Most of these techniques detect single species of pathogenic bacteria on a single interface. This approach, although very useful, does not meet the demands for clinical diagnosis, especially for early diagnosis of acute bacterial infections entailing multiple pathogenic bacterial infections with similar clinical symptoms. Although challenging, it is critical to develop multiplexed electrochemical biosensors for simultaneous detection of different pathogenic bacteria.

With the emergence of sophisticated biotechnology and nanotechnology techniques, various electrochemical strategies have been described for concurrent detection of chemicals and proteins [@B17]-[@B21]. Lu et al demonstrated the simultaneous detection of adenosine and cocaine in a single solution with Quantum dot-encoded aptamer sensors [@B17]. Hansen and coworkers reported a sensitive and selective bioelectronic assay for several proteins by coupling aptamers with the amplification features of inorganic nanocrystals [@B19]. Although significant advantages have been achieved by using these strategies, improvements are still needed to improve their sensitivity and applicability for simultaneous detection of different pathogenic bacteria.

The critical challenge was to improve the detection sensitivity based on an efficient amplification strategy. The normal immune-technology methods for the detection of pathogenic bacteria do not permit the amplification of antibodies directly. Recently, nucleic acids have gained special attention for signal amplification, where various approaches with excellent design and plasticity, such as hybridization chain reaction (HCR), could be employed. Cascade amplification could be obtained *via* HCR by extending from an initiator (short, specific nucleotide sequence) to a long repeated nucleotide sequence [@B22]-[@B27]. Therefore, a significant enhancement of the detection signal and sensitivity could be expected by labeling the detection antibody of pathogenic bacteria with nucleotide sequences, introducing HCR amplification, and attaching a large number of signal indicators on these repeated nucleotide sequences. Another strategy to improve the detection sensitivity was to increase the number of labeled signal indicators on signal probes. Normally, the signal probes could be conjugated to the antibodies directly. With the rapid development of nanotechnology, a variety of nanomaterials with large surface areas have been widely employed as nanocarriers to increase the number of signal probes modified on the antibodies. In this respect, gold nanoparticles (AuNPs), because of their good conductivity and biocompatibility, were used for improving the detection sensitivity. Recently, C~60~ has gained credence in the electrochemistry field because of its very rich electronic properties. C~60~ can adsorb metal nanomaterials, such as AuNPs to form AuNPs modified C~60~ (C~60~\@AuNPs) *via* intermolecular bonds and molecule-substrate interactions. Subsequently, C~60~\@AuNPs can modify a large number of antibodies or nucleic acids as nanocarriers for an increased sensitivity and an improved detection limit [@B28]. Considering the potential of C~60~\@AuNPs and high amplification efficiency of HCR, we combined the C~60~\@AuNPs as nanocarriers to adsorb a large number of initiators and generate HCR amplification. This combination resulted in exponentially large number of signal indicators forming efficient multifunctional nanoconjugates for ultrasensitive detection of pathogenic bacteria.

Herein, we propose a simultaneous electrochemical strategy for the ultrasensitive detection of *E. coli* O157:H7 and *Vibrio cholerae* O1 based on the specific immune recognition of these pathogenic bacteria and signal amplification *via* multifunctional nanoconjugates. First, the biotinylated antibodies for *E. coli* O157:H7 and *Vibrio cholerae* O1 were attached to streptavidin-coated magnetic beads (MB\@SA). Next, the detection antibodies were labeled with exponentially large amounts of signal indicators (CdS and PbS nanoparticles)-labeled signal probes *via* C~60~\@AuNPs as nanocarriers and HCR amplification. Thus, the biosensor could capture functionalized detection antibodies by antibody-antigen interactions in the presence of the *E. coli* O157:H7 and *Vibrio cholerae* O1. The electrochemical signals generated on different potentials were significantly enhanced and were proportional to the concentration of *E. coli* O157:H7 and *Vibrio cholerae* O1. Based upon our results presented in this study, it could be speculated that, in the future, electrochemical biosensors would be of great clinical significance. Highly sensitive and simultaneous monitoring of several pathogenic bacteria and other substances is expected to enable early detection of a variety of diseases.

2. Experimental {#Section2}
===============

2.1. Reagents and Materials {#Section2.1}
---------------------------

Monoclonal antibodies to *E. coli* O157:H7 (ab20976 and ab13625) and polyclonal antibodies to *Vibrio cholerae* O1 (ab79794 and ab79793) were purchased from Abcam (Cambridge, MA, USA). Heat-killed *E. coli* O157:H7 and *Vibrio cholerae* O1 were a gift from the Department of Clinical Microbiology and Immunology, College of Laboratory Medicine, Third Military Medical University (Chongqing, China). MB\@SA, C~60~, mercaptoacetic acid (MPA), 1-ethyl-3-\[3-(dimethylamino)propyl\] carbodiimide hydrochloride (EDC), gold chloride (HAuCl~4~) and sodium citrate were purchased from Sigma Chemical Co. (St. Louis, MO, USA). All other materials used were of analytical grade and purchased from Chemical Reagent Company (Chongqing, China). Phosphate buffered saline (PBS) was prepared with Na~2~HPO~4~, KH~2~PO~4,~ and KCl, and PBS with tween-20 (PBST) was prepared by adding 10% tween-20 to PBS. Ultrapure water with a resistivity of 18.2 MΩ/cm was used for all reagents.

All oligonucleotides were custom-synthesized by Shanghai Sangon Biological Engineering Technology and Services Co., Ltd. (Shanghai, China). Details of the oligonucleotides are listed in Table [S1](#SM1){ref-type="supplementary-material"}. Before using, all of the hairpin nucleotides were heated to 95 °C for 2 min and then cooled to room temperature to form stem-loop structures.

2.2. Apparatus {#Section2.2}
--------------

Electrochemical measurements including cyclic voltammetry (CV), anodic stripping voltammetry (ASV) and electrochemical impedance spectroscopy (EIS) measurements were performed by a Zennium electrochemistry workstation (ZAHNER-Elektrik GmbH & Co. KG, Germany) with a conventional three-electrode system containing a platinum wire as auxiliary electrode, a saturated calomel electrode (SCE) as reference electrode and a glassy carbon plate (GCP) with/without magnetic adsorption of magnetic beads as working electrode, respectively. The morphological characterizations were carried out with JSM-7800 Extreme-resolution analytical field emission scanning electron microscope (SEM, Jeol Inc., MA, USA) and Tecnai G2 F20 field-emission high-resolution transmission electron microscope (STEM, FEI, USA). Raman spectrometer was obtained using a Renishaw Invia Raman spectrometer with 50-objective, which was calibrated first by a silicon wafer at 520 cm^-1^ Raman shift before each measurement.

2.3. Preparation of the Biotinylated Antibodies {#Section2.3}
-----------------------------------------------

The antibodies for *E. coli* O157:H7 and *Vibrio cholerae* O1 were biotinylated according to the manufacturer\'s instructions [@B29]. Briefly, the appropriate NHS-biotin solution was added into the PBS solution with antibodies for *E. coli* O157:H7 (1 mg/mL) for the reaction between NHS group on NHS-biotin and amine groups on antibodies. The reaction was carried out at 37 °C for 2 h after mixing thoroughly. Finally, the biotinylated antibodies for *E. coli* O157:H7 were purified by desalination. The biotinylated antibodies for *Vibrio cholerae* O1 were prepared based on a similar protocol. The biotinylated antibodies were stored at 4 °C until further use.

2.4. Preparation of PbS and CdS Nanoparticles {#Section2.4}
---------------------------------------------

PbS nanoparticles were prepared according to the literature with MPA as a stabilizer [@B30]. Briefly, the Pb(NO~3~)~2~ and Na~2~S solutions were filtered through a 22 μm microporous membrane filter. Subsequently, 9.22 μL MPA was added to 50 mL 0.4 mM Pb(NO~3~)~2~ solution. After adjusting pH to 7 and bubbling with nitrogen for 30 min, 15 mL Na~2~S solution (1.34 mM) was slowly added to the mixture solution. Under nitrogen protection, the reaction was carried out for 24 h to obtain PbS nanoparticles.

CdS nanoparticles were prepared according to the previously described method with minor modifications [@B31]. Briefly, 90 μL MPA was added into 20 mL 20 mM CdCl~2~ solution and the pH was adjusted to 10 with 1 M sodium hydroxide solution. Subsequently, 20 mL 20 mM thioacetamide was slowly added to the solution with continuous stirring. The mixture was refluxed at 80 °C for 10 h to obtain CdS nanoparticles. After purification, the CdS nanoparticles were re-dispersed in ultrapure water and kept at 4 °C when not in use.

2.5. Preparation PbS and CdS Nanoparticles-Functionalized Oligonucleotide {#Section2.5}
-------------------------------------------------------------------------

The PbS nanoparticles were labeled on to oligonucleotides according to previous literature with a minor modification [@B32]. Briefly, 15 μL 0.1 M imidazole solution (pH 6.8) was added to 100 μL 5-amino group-capped oligonucleotides (signal probe 1, 100 μM) with complete mixing. Next, the mixture and 25 μL 0.1 M EDC were added to 2.0 mL PbS nanoparticles solution with magnetic stirring, and the reaction was kept at room temperature for 24 h with continuous stirring. The synthesized oligonucleotide bioconjugated PbS nanoparticles (PbS-SP) were collected by centrifugation at 11000 rpm and re-suspended in water. The PbS-SP were stored at 4 °C. The oligonucleotide bioconjugated CdS nanoparticles (CdS-SP) were prepared by the same protocol.

2.6. Preparation of Functionalized Detection Antibodies {#Section2.6}
-------------------------------------------------------

As shown in Scheme [1](#SC1){ref-type="fig"}, the antibodies were multi-functionalized with oligonucleotide bioconjugated CdS or PbS nanoparticles and amplified with HCR amplification. Typically, the C~60~ nanoparticles were first modified with thiol groups by the condensation of 30 mg C~60~ powder, 18.5 mg sarcosine, and 8.3 mg 10-mercaptodecyl aldehyde in 90 mL toluene and refluxing for 24 h under the N~2~ atmosphere [@B33]. After purification, the obtained thiolated C~60~ nanoparticles were modified with AuNPs, which were prepared according to the literature and characterized with average particle size of 16 nm [@B34]. In a typical experiment, 300 μL of prepared AuNPs were added into 1.7 mL thiolated C~60~ solution and the mixture was held with magnetic stirring at 4 °C for 12 h. After purification, the AuNPs-modified C~60~ nanoparticles (C~60~\@AuNPs) were stored at 4 °C for further use.

To conjugate the signal probes (CdS- or PbS-modified oligonucleotides) on antibodies and amplify with HCR amplification, 10 μL nucleotide initiator 1 and 2 μL detection antibodies for *E. coli* O157:H7 were added to 1 mL C~60~\@AuNPs solution and the mixture was kept at 4 °C for 12 h to functionalize the C~60~\@AuNPs. 100 μL 0.1 M HT solution was then added to the mixture to block the nonspecific sites. The prepared nucleotide initiator-labeled antibodies with AuNPs\@C~60~ was incubated with 1 μM hairpin nucleotide 1 and 2 in 6.67 mM Tris-HCl buffer (pH 8.0) containing 66.67 mM MgCl~2~ for 30 min. The resultant product, detection antibodies for *E. coli* O157:H7 labeled with a large amount of repeated nucleotide sequence based on HCR reactions, was then further reacted with 6 mM PbS-labeled signal probe (PbS-SP) by hybridization between the signal probe and associated sequences on the long repeated nucleotide sequences. The nucleotide initiator 2 and detection antibodies for *Vibrio cholerae* O1 was prepared and further connected with the CdS-labeled signal probe (CdS-SP) using the same protocol.

2.7. Measurement Procedure {#Section2.7}
--------------------------

Before the electrochemical measurements, the glassy carbon plate (GCP) was polished with alumina slurries (0.3 and 0.05 µm, respectively), ultrasonicated in ethanol and distilled water, and dried with nitrogen. Subsequently, the cleaned GCP was modified with a gold nano-layer by electrodeposition in HAuCl~4~ (1%) solution at the potential of -0.2 V for 30 s. Finally, the gold nano-layer modified glassy carbon plate (DepAu/GCP) was dipped in 0.1 M HT to block the nonspecific sites.

In this study, the electrochemical measurements were performed based on a sandwich type assay in a tube as shown in Scheme [1](#SC1){ref-type="fig"}. Briefly, the biotinylated primary antibodies for *E. coli* O157:H7 and for *Vibrio cholerae* O1, PbS-labeled signal probe (CdS-SP)-functionalized detection antibodies for *E. coli* O157:H7 and CdS-labeled signal probe (CdS-SP)-functionalized detection antibodies for *Vibrio cholerae* O1 were first added to the solution with streptavidin-coated magnetic beads (MB\@SA). After addition of test sample, the mixture was incubated at 37 °C for 40 min. Next, the mixture was employed for the electrochemical measurements with the self-designed magnetic, electrochemical sensor. After each determination, the magnetic electrochemical sensor could be regenerated simply by washing twice with PBST. Details of the magnetic, electrochemical sensor are described in the [Supporting Information](#SM1){ref-type="supplementary-material"} Figure [S2](#SM1){ref-type="supplementary-material"}.

2.8. Preparation of the Synthetic Samples and Safety Consideration {#Section2.8}
------------------------------------------------------------------

The bacteria were maintained in brain-heart infusion at 37 °C for 20 h following which the concentration was determined by the conventional PCR technology. The bacteria were heated at 100 °C for 15 min to kill all of the bacteria. The pure cultures were serially diluted to different concentration with PBS as the synthetic samples.

3. Results and Discussion {#Section3}
=========================

3.1. Morphology and Structure Characterization of the Nano-materials {#Section3.1}
--------------------------------------------------------------------

The morphology of the CdS and PbS nanoparticles were characterized by STEM (Figure [1](#F1){ref-type="fig"}A and B, respectively). As shown in Figure [1](#F1){ref-type="fig"}A, the CdS nanoparticles presented a spherical structure with an average diameter of 4 nm. For the PbS nanoparticles (Figure [1](#F1){ref-type="fig"}B), the average diameter was about 10 nm. The excellent nucleation and dispersion of CdS and PbS nanoparticles indicated the suitability of their application as signal probes. The MB\@SA used in this study and the immunoreaction on the magnetic beads were characterized by SEM and zeta potential measurements. As displayed in Figure [1](#F1){ref-type="fig"}C, the SEM image of MB\@SA revealed a spherical structure with an average diameter of 1.30 μm (the particle size distribution is shown in the [Supporting Information](#SM1){ref-type="supplementary-material"} Figure [S5](#SM1){ref-type="supplementary-material"}A) and zeta potential of 14.7 mV. When the capture antibodies were conjugated onto the surface of MB\@SA (Figure [1](#F1){ref-type="fig"}D), the diameter of the beads was increased to 1.33 μm with some irregular bulges on the surface. At the same time, the zeta potential was changed to 23.2 mV due to the addition of antibodies on the surface of MB\@SA [Supporting Information](#SM1){ref-type="supplementary-material"} Figure [S5](#SM1){ref-type="supplementary-material"}B). All these results indicated successful attachment of capture antibodies on the MB\@SA surface which was critical for the immunoassay based on electrochemical strategy in this study.

3.2. Characteristics of the Electrochemical Strategy {#Section3.2}
----------------------------------------------------

CV, the powerful electrochemical technology to characterize the information on reagent immobilization, electroactivity, and stability, was employed to study the immobilization of magnetic beads on the self-designed magnetic electrochemical sensor. As shown in Figure [2](#F2){ref-type="fig"}A, with the CV performance in 2 mM Fe(CN)~6~^3-/4-^ with 0.1 M KCl, a pair of well-defined redox peaks of Fe(CN)~6~^3-/4-^ could be observed for the bare GCP (curve a). After the electrochemical deposition of DepAu onto the GCP (curve b), the peak currents were increased due to the good conductivity and electron transfer ability of DepAu. When the DepAu-modified GCP (DepAu/GCP) was blocked with HT (curve c), the peak currents were decreased. After magnetic adsorption of the MB\@SA (curve d), the peak currents were decreased even more indicating the stable immobilization of MB\@SA which was helpful for the efficient electrochemical determination. For the electrochemical response after magnetic adsorption of the MB\@SA with capture antibodies, a decreased peak current could clearly be observed (curve e). This is because the antibodies on the surface of MB\@SA retard the electron transfer due to the increased steric hindrance effect.

Further characterizations *via* EIS in 0.1 M PBS with 5 mM \[Fe(CN)~6~\]^3-/4-^ at a frequency range from 5 × 10^-2^ to 1 × 10^6^ Hz in a given open circuit voltage with an amplitude of 10 mV are shown in Figure [1](#F1){ref-type="fig"}B. The electron transfer resistance (*R*~et~) was employed to demonstrate the electron transfer kinetics quantitatively which was similar to the semicircle diameter in EIS response in the form of a Nyquist plot. For the bare GCP (curve a), a normal EIS response was received with *R*~et~ of about 60 Ω. After the electrochemical deposition of DepAu onto the GCP surface, an obviously decreased *R*~et~ was observed (curve b, *R*~et~ ≈ 20 Ω). When the DepAu-modified GCP was blocked with HT (curve c), an increased *R*~et~ about of 200 Ω was obtained. Furthermore, the *R*~et~ was increased to about 700 Ω after magnetic adsorption of the reacted MB\@SA (curve d). After magnetic adsorption of the MB\@SA reacted with capture antibodies, the *R*~et~ was increased to 800 Ω due to the retardation of electron transfer *via* the increased steric hindrance effect (curve e). These EIS results indicated the same tendency of electron transfer as that obtained by CVs, and quantified the electron transfer kinetics with accurate *R*~et~. These EIS and CV measurements could confirm the successful fabrication of the proposed electrochemical strategy.

3.3. Characterization of the Signal Amplification {#Section3.3}
-------------------------------------------------

In this study, the signal was amplified by C~60~\@AuNPs as nanocarriers and HCR amplification. To evaluate the efficiency of signal amplification, three analysis modes were prepared for the detection of *E. coli* O157:H7 and *Vibrio cholerae* O1 simultaneously: CdS- or PbS-labeled antibodies without C~60~\@AuNPs as nanocarriers and HCR amplification (Figure [S6](#SM1){ref-type="supplementary-material"}A), CdS- or PbS-labeled antibodies with AuNPs as nanocarriers and HCR amplification (Figure [S6](#SM1){ref-type="supplementary-material"}B), and CdS- or PbS-labeled antibodies with C~60~\@AuNPs as nanocarriers and HCR amplification (Figure [S6](#SM1){ref-type="supplementary-material"}B). As shown in Figure [S6](#SM1){ref-type="supplementary-material"}A, there were two current peaks for PbS and CdS nanoparticles with current signals of about 5 μA. For CdS- or PbS-labeled antibodies with AuNPs as nanocarrier and HCR amplification (Figure [S6](#SM1){ref-type="supplementary-material"}B), an improvement to the electrochemical response was obtained with current signal of about 12 μA. For CdS- or PbS-labeled antibodies with HCR amplification (Figure [S6](#SM1){ref-type="supplementary-material"}C), a 2-fold enhancement was obtained. From these results, it became obvious that the amplification of C~60~\@AuNPs as nanocarriers and HCR amplification could be employed for the detection of *E. coli* O157:H7 and *Vibrio cholerae* O1 simultaneously.

The nucleotides employed for the HCR amplification were characterized by polyacrylamide gel electrophoresis (Figure [S1](#SM1){ref-type="supplementary-material"}. The molecular weights of the nucleotides in the experiment were characterized by distribution places of the UV band from notches. The HCR reaction could be triggered by nucleotide initiator with hairpin nucleotides forming long nucleotides polymers (lane 5 and lane e). Importantly, the long nucleotides polymers with large molecular weights could attach massive signal probes for the enhancement of electrochemical responses associated with the nucleotide initiator. Thus, the electrochemical responses could be employed to indicate the concentration of nucleotide initiator and associated antibodies with improved sensitivity and efficiency.

3.4. Specific Reaction of the Electrochemical Assay {#Section3.4}
---------------------------------------------------

To investigate the specific reaction of the proposed multiplexed assay *via* electrochemical characterization, the biosensor was used to analyze different samples with the same assay mode, including 1) no targets, 2) *E. coli* O157:H7, 3) *Vibrio cholerae* O1 and 4) the mixture of *E. coli*O157:H7 and *Vibrio cholerae* O1. As shown in Figure [3](#F3){ref-type="fig"}A, without a target, no obvious current peak could be observed. When using *E. coli* O157:H7 or *Vibrio cholerae* alone as target, current peaks for CdS and PbS could be detected at about - 0.7 V and - 0.4 V, respectively (Figures [3](#F3){ref-type="fig"}B & C). When the *E. coli* O157:H7 and *Vibrio cholerae* O1 together were used as detection targets, two strong current peaks at - 0.7 V and - 0.4 V could be observed (Figure [3](#F3){ref-type="fig"}D). More importantly, the current peaks did not interfere with each other, indicating the signals of *E. coli* O157:H7 and *Vibrio cholerae* O1probes could be employed for their simultaneous detection on a single interface in a single run.

Another important technology, Raman spectrometry, was also employed to confirm the specific reactions of the electrochemical assay (Figure [3](#F3){ref-type="fig"}E-H). There was no obvious Raman peak from 180 cm^-1^ to 450 cm^-1^ for the interface without *E. coli* O157:H7 and *Vibrio cholerae* O1 (Figure [3](#F3){ref-type="fig"}E). With *E. coli* O157:H7 alone, there was a single Raman peak at about 300 cm^-1^ (Figure [3](#F3){ref-type="fig"}F), which was the characteristic Raman peak for CdS [@B35]. For the detection of *Vibrio cholerae* O1 alone, a single Raman peak could be observed at about 230 cm^-1^ (Figure [3](#F3){ref-type="fig"}G), indicating the presence of the PbS nanoparticles [@B36]. When the proposed biosensor was employed for the simultaneous detection of *E. coli* O157:H7 and *Vibrio cholerae* O1 on a single interface (Figure [3](#F3){ref-type="fig"}H), two Raman peaks were present at about 230 cm^-1^ and 300 cm^-1^ pertaining to PbS and CdS nanoparticles, respectively. This again indicated the acceptable specificity of the electrochemical strategy for the simultaneous detection of *E. coli*O157:H7 and *Vibrio cholerae*O1.

3.5. Analytical Characteristics of the Biosensor {#Section3.5}
------------------------------------------------

We evaluated the performance of the electrochemical biosensor for simultaneous determination of different concentrations of *E. coli*O157:H7 and *Vibrio cholerae*O1 in standard solution. As displayed in Figure [4](#F4){ref-type="fig"}A, the current signals were increased according to the concentrations of *E. coli* O157:H7 and *Vibrio cholerae* O1 in the range from 5×10^1^ to 1×10^6^ CFU/mL. Also, a good linear relationship with the logarithm concentrations of *E. coli*O157:H7 and *Vibrio cholerae* O1 can be seen in Figure [4](#F4){ref-type="fig"}B and C, with egression equation of ∆*I* (µA) = 3.43log *c*~O157:H7~ - 5.05 and ∆*I* (µA) = 3.51log*c*~O1~ - 4.54, and detection limit of 39 CFU/mL and 32 CFU/mL, respectively; this equation was defined as LOD = 3*S*~B~/*m*, where *S~B~* was the standard deviation of the blank and *m* was the analytical sensitivity. These results indicated that the *E. coli* O157:H7 and *Vibrio cholerae* O1 concentrations could be quantitatively measured by the electrochemical signal using the proposed biosensor. Furthermore, the performance of the proposed biosensor was compared with that of the previously reported studies as shown in Table [1](#T1){ref-type="table"}. The results indicated the superior sensitivity of the biosensor for the detection of bacteria with a low detection limit and wide linear range.

The reproducibility of the biosensor, which constitutes an important feature, was investigated by intra-assay and inter-assay coefficients of variation with 10 biosensors incubated individually with standard solutions of *E. coli* O157:H7 and *Vibrio cholerae* O1 [Supporting Information](#SM1){ref-type="supplementary-material"} Figure [S7](#SM1){ref-type="supplementary-material"}. The close current signals with intra-assay coefficient of variation 6.8% and 6.7% and inter-assay coefficient of variation 5.3% and 6.6% for *E. coli* O157:H7 and *Vibrio cholerae* O1 respectively, indicated the acceptable reproducibility of the biosensor for simultaneous detection of *E. coli* O157:H7 and *Vibrio cholerae* O1. The stability, another important factor of the biosensor, was investigated by long-term storage assay. After a storage period of 30 days at 4 ºC, the current response retained 93.6% of its initial response, suggesting the satisfactory stability of the biosensor.

3.6. Analysis of Synthetic Samples {#Section3.6}
----------------------------------

To investigate the feasibility of the biosensor for evaluating the laboratory and clinical samples, the study results of human stool samples and water samples were compared with that obtained by the plate count method. Preparation of these samples is shown in the [Supporting Information](#SM1){ref-type="supplementary-material"}. As shown in Figure [5](#F5){ref-type="fig"} for the determination of *E. coli* O157:H7 and *Vibrio cholerae* O1, both the correlation coefficient and slope were close to 1, indicating a good agreement between the study results of the biosensor and those from the plate count method (insert: the concentration range of *E. coli* O157:H7 and *Vibrio cholerae* O1 obtained by the electrochemical biosensor and the plate count method, respectively). These results indicated that the biosensor was feasible for the determination of *E. coli* O157:H7 and *Vibrio cholerae* O1, could satisfy the need for practical analyses, and provided an efficient approach for the simultaneous detection of bacteria for clinical diagnosis, disease prevention, environmental analysis, and food safety.

4. Conclusion {#Section4}
=============

In summary, an electrochemical biosensor was developed for sensitive and efficient simultaneous determination of *E. coli* O157: H7 and *Vibrio cholerae* O1 by utilizing nanotechnology and HCR amplification with self-designed magnetic electrochemical sensor. Using the proposed biosensor, the concentrations of these pathogenic bacteria could be established on a single interface in a single run. Furthermore, the biosensor displayed excellent performance with high sensitivity with a detection limit of 39 CFU/mL and 32 CFU/mL, respectively, for *E. coli* O157: H7 and *Vibrio cholerae* O1. This high sensitivity is an essential requirement for early clinical diagnosis, disease prevention, environmental analysis, and food safety. We believe that the successful establishment of the electrochemical biosensor would provide an efficient amplification approach for ultrasensitive molecular diagnostics for the detection of multiple pathogenic bacteria on a single interface in a single run. This simple method could be expanded readily for detecting other pathogenic bacteria and would be of great value for future applications in public and environmental safety.
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ASV

:   anodic stripping voltammetry

CdS-SP

:   oligonucleotide bioconjugated CdS nanoparticles or CdS labeled signal probe

CV

:   cyclic voltammetry

DepAu/GCP

:   gold nano-layer modified glassy carbon plate

EDC

:   1-ethyl-3-\[3-(dimethylamino)propyl\] carbodiimide hydrochloride

EIS

:   electrochemical impedance spectroscopy

*E. coli* O157

:   H7: *Escherichia coli*O157:H7

GCP

:   glassy carbon plate

HCR

:   hybridization chain reaction

C~60~\@AuNPs

:   AuNPs modified C~60~

MB\@SA

:   streptavidin coated magnetic beads

MPA

:   mercaptoacetic acid

HAuCl~4~

:   gold chloride

PBS

:   Phosphate buffered saline

PbS-SP

:   oligonucleotide bioconjugated PbS nanoparticles or PbS labeled signal probe

PBST

:   phosphate buffered saline with tween-20

SCE

:   saturated calomel electrode.

![Schematic representation of the simultaneous detection of pathogenic bacteria by the proposed electrochemical biosensor using *E. coli* O157:H7 and *Vibrio cholerae* O1 as a model: A, Schematic diagram of the simultaneous electrochemical system; B, Preparation of the bioconjugates- and nanoparticles-labeled antibodies; C, Schematic diagram of the immunoassay on magnetic beads. Abbreviations: Ab(O157) or Ab(O1), antibodies for *E. coli* O157:H7 or *Vibrio cholerae* O1; Bio-Ab, biotinylated antibodies; H1-4, hairpin nucleotide for HCR reaction; MB\@SA, streptavidin-coated magnetic beads; NI1-2, nucleotide initiator; SP1-2, signal probe. (The schematic diagram is helpful for understanding the fabrication of the electrochemical assay, but it is not in proportion).](thnov07p0935g001){#SC1}

![Structure and morphology of the nanoparticles: (A) CdS nanoparticles; (B) PbS nanoparticles; (C) MB\@SA; (D) MB\@SA/capture antibodies. Inserts show the HTEM and SEM images with high amplification for CdS (A), PbS (B), MB\@SA (C) and MB\@SA/capture antibodies (D).](thnov07p0935g002){#F1}

![Characterization of the electrochemical measurements by self-designed magnetic electrochemical sensor: (A) CV; (B) EIS. The labeling a through e denote: a, bare GCP; b, DepAu-modified GCP; c, DepAu-modified GCP blocked with HT; d, fabricated GCP after adsorption with MB\@SA; e, fabricated GCP with capture antibodies on the surface of MB\@SA. Insert of Figure [2](#F2){ref-type="fig"}B is the EIS characterization of bare GCP (a) and DepAu modified GCP (b) with high amplification.](thnov07p0935g003){#F2}

![Specific reactions of the multiplexed assay: (A-D) electrochemical characterizations; (E-H) Raman scattering. The electrochemical and Raman responses show the raw results subtracted from the background responses.](thnov07p0935g004){#F3}

![Electrochemical signals as a function of concentrations of *E. coli* O157:H7 and *Vibrio cholerae*. (A) Electrochemical responses of the electrochemical biosensor at different concentrations of *E. coli* O157:H7 and *Vibrio cholerae* O1 (curves a-i, with concentration of 0, 5 × 10, 1 × 10^2^, 5 × 10^2^, 1 × 10^3^, 5 × 10^3^, 1 × 10^4^, 5 × 10^4^, 1 × 10^5^, 2.5 × 10^5^, 5 × 10^5^ and 1 × 10^6^ CFU/mL, respectively); (B) Calibration curve for the relationship between electrochemical signals and concentrations of *E. coli* O157:H7; (C) Calibration curve for the relationship between electrochemical signals and concentrations of *Vibrio cholerae* O1.](thnov07p0935g005){#F4}

![Relationship between the concentrations of *E. coli* O157: H7 (A) and *Vibrio cholerae* O1 (B) detected by the as-proposed biosensor and plate count method. Insert: The concentration range for the concentration of *E. coli* O157:H7 (a) and *Vibrio cholerae* O1 (b) respectively by box chart (box, 25%-75% value range; line, 10%-90% value range; ☆, mean value; ▲, max value; ▼, min value).](thnov07p0935g006){#F5}

###### 

Comparison between the electrochemical assay with multifunctional conjugates and other recent studies

  ----------------------------------------------------------------------------------------------------------
                         Method        Detection limit\            Linear range\                 Reference
                                       CFU mL^-1^                  CFU mL^-1^                    
  ---------------------- ------------- --------------------------- ----------------------------- -----------
  *E. coli* O157:H7      **ECA^a^**    412                         4.12 × 10^2^ - 4.12 × 10^5^   14

  **FAb**                25            4 × 10 - 4 × 10^5^          37                            

  **CLAc**               7.6 × 10^3^   0 - 5 × 10^5^               38                            

  **LAPSd**              2.5 × 10^4^   n/a                         39                            

  **PCRe**               1.3 × 10^4^   n/a                         40                            

  **ECA**                39            5 × 10 - 1 × 10^6^          Present work                  

  *Vibrio cholerae* O1   **ECA**       100                         1.0 × 10^2^ - 1.0 × 10^7^     8

  **FA**                 50            n/a                         9                             

  **DFMf**               1.0 × 10^3^   1.0 × 10^3^ - 1.0 × 10^6^   41                            

  **ECA**                32            5 × 10 - 1 × 10^6^          Present work                  
  ----------------------------------------------------------------------------------------------------------

^a^ ECA, electrochemical assay;

^b^ FA, fluorescent assay;

^c^ CLA, chemiluminescent assay;

^d^ LAPS, light-addressable potentiometric sensor;

^e^ PCR, polymerase chain reaction;

^f^ DFM, dynamic force microscopy.
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